About Medivation, Inc
Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer’s disease, Huntington’s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company’s subsidiary Medivation – more... Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.
(Source: 10-K) – less – More from ZoomInfo »
Medivation, Inc Employer Reviews
Working at Medivation, Inc
